Pharmacological properties of naproxen.
D000284:Administration, Oral; D000287:Administration, Topical; D000700:Analgesics; D000707:Anaphylaxis / Q000188:drug therapy; D000818:Animals; D000893:Anti-Inflammatory Agents; D001241:Aspirin / Q000627:therapeutic use; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D004487:Edema / Q000188:drug therapy; D005577:Forssman Antigen; D006099:Granuloma / Q000188:drug therapy; D006168:Guinea Pigs; D006854:Hydrocortisone / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D008738:Methyl Ethers / Q000494:pharmacology; D009020:Morphine / Q000627:therapeutic use; D009281:Naphthalenes / Q000494:pharmacology; D010031:Otitis / Q000188:drug therapy; D010653:Phenylbutazone / Q000627:therapeutic use; D011422:Propionates / Q000494:pharmacology; D051381:Rats; D012119:Respiration / Q000187:drug effects
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D008738:Methyl Ethers; D009281:Naphthalenes; D011422:Propionates; D009020:Morphine; D005577:Forssman Antigen; D010653:Phenylbutazone; D001241:Aspirin; D006854:Hydrocortisone; D007213:Indomethacin